Expanded TAVR Coverage; Point-of-Care Troponins; 90-Year-Olds and PCI
(MedPage Today) -- CMS expanded access to transcatheter aortic valve replacement (TAVR). Gone is the Coverage with Evidence Development (CED) requirement for symptomatic severe aortic stenosis (AS), and newly in place is coverage for asymptomatic...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.